Norvang, Vibeke
Haavardsholm, Espen A.
Tedeschi, Sara K.
Lyu, Houchen
Sexton, Joseph
Mjaavatten, Maria D.
Kvien, Tore K.
Solomon, Daniel H.
Yoshida, Kazuki
Article History
Received: 23 December 2021
Accepted: 12 May 2022
First Online: 28 May 2022
Declarations
:
: The ARCTIC trial was approved by an independent ethics committee (the Regional Committee for Medical and Health Research Ethics South-East; reference number 2010/744). Patients gave written informed consent prior to inclusion in the study. The NOR-VEAC study was approved by an independent ethics committee (the Regional Committee for Medical and Health Research Ethics South-East; reference number 2010/719). Patients gave written informed consent prior to inclusion in the study. Both studies were conducted in accordance with the guidelines and regulations applicable in Norway.
: Not applicable.
: E. A. Haavardsholm has received research grants to the ARCTIC trial from AbbVie, MSD, Pfizer, Roche and UCB; all other authors declare no conflict of interest.